Determination of Vancomycin and Methicillin Resistance in Clinical Isolates of Staphylococcus aureus in Iranian Hospitals

Aims: The aim of this study was to determine the prevalence of methicillin resistant S. aureus (MRSA), vancomycin resistant or vancomycin intermediate resistant S. aurues (aureus) (VRSA/VISA) among clinical isolates. Study Design: S.aureus isolates used in this study were randomly collected from in-patient and outpatient of several hospitals of 7 cities in Iran (Tehran, Shiraz, Zahedan, Tabriz, Sannandaj, Sari, and Ahvaz) during 2006-2008. Methodology: Antibiotic susceptibility of 250 strains of Staphylococcus aureus isolated from Iranian hospitals were determined by disk diffusion method. Minimum inhibitory concentration (MICs) were determined for oxacillin and vancomycin by E-test. PCRs were used by specific primers (PCR used specific primers) for detection of mecA, vanA, vanB genes. Results: The percentage of resistance by disk diffusion method was as below: methicillin 46%, vancomycin 0%, penicillin 86%, erythromycin 42%, ciprofloxacin 29%, gentamicin 39% and clindamycin 33%. E-test MIC method showed that 43% isolates were resistant to Original Research Article British Microbiology Research Journal, 4(4): 454-461, 2014 455 methicillin and 4% isolates were VISA (≤ 8μg/ml). The prevalence of resistance genes in the clinical isolates were: mecA 44%, vanA 0%, vanB 0%. Conclusion: This study revealed that clinical isolates have rather high resistance to methicillin, erythromycin, gentamicin, penicillin and clindamycin We did not observe resistance to vancomycin. In order to avoid a possible outbreak involving VISA), vancomycin should be used carefully as a drug for treatment of S. aureus infections.